Related Experiment Video
Updated: Mar 17, 2026
08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
1.5K
Ginsenoside Rb1 alleviates aluminum chloride-induced rat osteoblasts dysfunction
Yanzhu Zhu1, Chongwei Hu2, Peihe Zheng1
1Institute of Special Animal and Plant Sciences of Chinese Academy of Agricultural Sciences, Changchun 130112, China.
Toxicology
|July 30, 2016
Summary
Ginsenoside Rb1 (Rb1) effectively reverses aluminum-induced osteoblast dysfunction. This study shows Rb1 protects bone cells from aluminum toxicity, reducing oxidative stress and improving cell viability for potential osteoporosis treatment.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Aluminum (Al) exposure induces osteoblast dysfunction, contributing to osteoporosis.
- Ginsenoside Rb1 (Rb1) exhibits therapeutic potential for osteoporosis treatment.
Purpose of the Study:
- To evaluate the efficacy of Rb1 in mitigating aluminum chloride (AlCl3)-induced osteoblast dysfunction.
- To investigate the protective mechanisms of Rb1 against aluminum toxicity in osteoblasts.
Main Methods:
- Osteoblasts were cultured and treated with Rb1, AlCl3, or a combination.
- Assessed osteoblast viability, mRNA expression of growth factors (TGF-β1, BMP-2, IGF-I, Cbfα1), antioxidant enzyme activities (GSH-Px, SOD), and reactive oxygen species (ROS) concentration.
- Examined osteoblast ultrastructural features.
Main Results:
- Rb1 treatment significantly increased osteoblast viability, TGF-β1, BMP-2, IGF-I, and Cbfα1 mRNA expression in AlCl3-exposed cells.
- Rb1 significantly enhanced GSH-Px and SOD activities while decreasing ROS concentration.
- Histological lesions in osteoblasts were attenuated by Rb1 treatment.
Conclusions:
- Rb1 effectively ameliorates AlCl3-induced osteoblast dysfunction by reversing viability reduction and inhibiting oxidative stress.
- Rb1 demonstrates potential as a therapeutic agent for aluminum-related bone diseases like osteoporosis.
